Target Name: EBF1
NCBI ID: G1879
Review Report on EBF1 Target / Biomarker Content of Review Report on EBF1 Target / Biomarker
EBF1
Other Name(s): EBF1 variant 3 | COE1_HUMAN | EBF transcription factor 1, transcript variant 10 | Early B-cell factor | OLF1 | Collier, Olf and EBF transcription factor 1 | EBF1 variant 1 | COE1 | Early B-cell factor 1, transcript variant 1 | EBF1 variant 10 | early B cell factor 1 | OE-1 | EBF transcription factor 1 | Early B cell factor 1 | olfactory neuronal transcription factor 1 | Transcription factor COE1 (isoform 3) | EBF1 variant 2 | Transcription factor COE1 | Transcription factor COE1 (isoform 1) | EBF transcription factor 1, transcript variant 3 | EBF transcription factor 1, transcript variant 2 | Olfactory neuronal transcription factor 1 | EBF | O/E-1 | Transcription factor COE1 (isoform 2) | Transcription factor COE1 isoform 10

EBF1: A Drug Target / Disease Biomarker

EBF1, also known as EBF1A, is a protein that is expressed in various tissues of the body, including the brain, heart, and gastrointestinal tract. It is a member of the EBF family of proteins, which are known for their role in cell signaling and transcriptional regulation. One of the unique features of EBF1 is its ability to interact with various signaling pathways, including the AP-1/CREB signaling pathway. This interaction has led to the conclusion that EBF1 may be a drug target or biomarker for a variety of diseases.

The AP-1/CREB signaling pathway is a well-established network that plays a crucial role in the regulation of gene expression and cell behavior. It is composed of several transcription factors, including AP-1,CREB, and p300, which are involved in the regulation of transcription factor-dependent gene expression. The AP-1 gene is located on chromosome 1 and encodes a transcription factor that is involved in the regulation of cell growth, differentiation, and survival. The CREB gene is located on chromosome 2 and encodes a transcription factor that is involved in the regulation of DNA replication and gene expression. The p300 gene is located on chromosome 12 and encodes a transcription factor that is involved in the regulation of gene expression and cell signaling.

EBF1 is a protein that has been shown to interact with the AP-1 and CREB transcription factors. This interaction is important for the regulation of various cellular processes, including cell growth, differentiation, and survival. One of the unique features of EBF1's interaction with these transcription factors is its ability to induce the expression of target genes that are involved in the regulation of cell signaling and metabolism.

In addition to its interaction with the AP-1 and CREB transcription factors, EBF1 has also been shown to interact with several other signaling pathways, including the TGF-β signaling pathway. The TGF-β pathway is a well-established network that plays a crucial role in the regulation of cell behavior and growth, and is composed of several transcription factors, including TGF-β1, TGF-β2, and BMP-2. The TGF-β1 gene is located on chromosome 5 and encodes a transcription factor that is involved in the regulation of cell growth and differentiation. The TGF-β2 gene is located on chromosome 10 and encodes a transcription factor that is involved in the regulation of cell growth and differentiation. The BMP-2 gene is located on chromosome 16 and encodes a transcription factor that is involved in the regulation of cell growth and differentiation.

The interaction between EBF1 and the TGF-β pathway is important for the regulation of various cellular processes, including cell growth, differentiation, and survival. One of the unique features of EBF1's interaction with this pathway is its ability to induce the expression of target genes that are involved in the regulation of cell signaling and metabolism.

EBF1 has also been shown to interact with several other signaling pathways, including the NF-kappa-B signaling pathway. The NF-kappa-B pathway is a well-established network that plays a crucial role in the regulation of cell behavior and inflammation, and is composed of several transcription factors, including NF-kappa-B1, NF-kappa-B2, and NF-kappa-B3. The NF-kappa-B1 gene is located on chromosome 4 and encodes a transcription factor that is involved in the regulation of cell growth and differentiation. The NF-kappa-B2 gene is located on chromosome 11 and encodes a transcription factor that is involved in the regulation of cell growth and differentiation. The NF-kappa-B3 gene is located on chromosome 16 and encodes a transcription factor that is involved in the regulation of cell growth and differentiation.

The interaction between EBF1 and the NF-kappa-B pathway is important for the regulation of various cellular processes, including cell growth, differentiation, and inflammation. One of the unique features of EBF1's interaction with this pathway is its ability to induce the expression of target genes that are involved in the regulation of cell signaling and metabolism.

In addition to its interaction with the AP-1,

Protein Name: EBF Transcription Factor 1

Functions: Key pioneer transcription factor of B-cell specification and commitment (PubMed:27807034). Recognizes variations of the palindromic sequence 5'-ATTCCCNNGGGAATT-3'. Operates in a transcription factor network to activate B-cell-specific genes and repress genes associated with alternative cell fates. For instance, positively regulates many B-cell specific genes including BCR or CD40 while repressing genes that direct cells into alternative lineages, including GATA3 and TCF7 for the T-cell lineage. In addition to its role during lymphopoiesis, controls the thermogenic gene program in adipocytes during development and in response to environmental cold (By similarity)

The "EBF1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about EBF1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

EBF2 | EBF3 | EBF4 | EBI3 | EBLN1 | EBLN2 | EBLN3P | EBNA1BP2 | EBP | EBPL | ECD | ECE1 | ECE1-AS1 | ECE2 | ECEL1 | ECEL1P1 | ECEL1P2 | ECH1 | ECHDC1 | ECHDC2 | ECHDC3 | ECHS1 | ECI1 | ECI2 | ECI2-DT | ECM1 | ECM2 | ECPAS | ECRG4 | ECSCR | ECSIT | ECT2 | ECT2L | Ectonucleoside triphosphate diphosphohydrolase | EDA | EDA2R | EDAR | EDARADD | EDC3 | EDC4 | EDDM3A | EDDM3B | EDEM1 | EDEM2 | EDEM3 | EDF1 | EDIL3 | EDIL3-DT | EDN1 | EDN2 | EDN3 | EDNRA | EDNRB | EDNRB-AS1 | EDRF1 | EDRF1-AS1 | EDRF1-DT | EEA1 | EED | EEF1A1 | EEF1A1P11 | EEF1A1P14 | EEF1A1P19 | EEF1A1P22 | EEF1A1P25 | EEF1A1P28 | EEF1A1P3 | EEF1A1P30 | EEF1A1P38 | EEF1A1P44 | EEF1A1P47 | EEF1A1P5 | EEF1A1P6 | EEF1A1P9 | EEF1A2 | EEF1AKMT1 | EEF1AKMT2 | EEF1AKMT3 | EEF1AKMT4 | EEF1B2 | EEF1B2P1 | EEF1B2P3 | EEF1B2P5 | EEF1B2P6 | EEF1D | EEF1DP1 | EEF1DP3 | EEF1E1 | EEF1E1-BLOC1S5 | EEF1G | EEF1GP2 | EEF1GP8 | EEF2 | EEF2K | EEF2KMT | EEFSEC | EEIG1 | EEIG2 | EEPD1 | EFCAB10